Stocks for Exact Sciences leaped 33% after it announced the acquisition of liquid biopsy rival Thrive and UK start-up Base Genomics. Exact Sciences said it has agreed to buy Thrive for a cash and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback